Seyed-Mohammad Fereshtehnejad

Karolinska Institute, Sweden


Seyed-Mohammad Fereshtehnejad is a medical doctor (M.D.) graduated from Iran University of Medical Sciences, Tehran, Iran in 2009. He also obtained Master of Public Health (M.P.H.) and Master of Medical Education (M.Sc.) degrees. He pursued his education in neuroscience obtaining a Ph.D. degree from Karolinska Institutet, Stockholm, Sweden in 2015. The focus of his doctoral thesis was on neuroepidemiology of Parkinson’s disease. Since 2016, he works as a postdoctoral research fellow at the Montreal Neurological Institute (MNI), McGill University in Montreal, Canada, and an associated researcher at the Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Sweden. His research interest includes neurodegenerative disorders, namely Parkinson’s disease, Alzheimer’s disease, and other dementias focusing on their epidemiology, data registries, and global impact. Since 2013, he is one of the members of the expert panel at the Global Burden of Disease (GBD) project, responsible for the epidemiology of neurodegenerative disorders including Parkinson’s disease. Furthermore, he has particular interests in subtyping of Parkinson’s disease, neuroimaging markers of disease progression, and prodromal stage of parkinsonism. Dr. Fereshtehnejad is the author of over 160 peer-reviewed publications and has been reviewing manuscripts regularly for top neurological journals. He is a member of the International Parkinson and Movement Disorder Society (MDS) and has mentored or co-supervised master’s and doctoral theses.

Biography Updated on 14 March 2018

Scholarly Contributions [Data Provided by ]